Our fully automatic soft bag large infusion production lines represent high-standard, turnkey manufacturing solutions for pharmaceutical intravenous infusion production. Engineered for high sterility, operational stability, and intelligent unmanned production, the integrated system covers the entire workflow from bag forming, liquid dosing, sealing, and sterilization to final packaging, delivering compliant, high-yield production for non-PVC soft bag infusion products.
Built with a highly integrated modular structure, the production line realizes full-process automated operation, effectively reducing human intervention and eliminating manual operation-related contamination risks and process errors. It supports continuous, streamlined manufacturing of various large-volume infusion formulations, including saline, glucose, and compound electrolyte infusions. With precise liquid filling control, stable heat-sealing performance and consistent forming quality, the equipment ensures excellent batch-to-batch uniformity and product qualification rate.
Designed in strict accordance with cGMP and global pharmaceutical manufacturing standards, the line adopts closed sterile production configurations, high-efficiency air purification systems, and automated CIP/SIP cleaning and sterilization functions. The whole production process features full environmental monitoring, parameter interlock control and complete data traceability, fully meeting the stringent validation requirements for pharmaceutical infusion production and helping enterprises pass domestic and international regulatory audits efficiently.
Optimized for industrial-scale mass production, our soft bag infusion production lines deliver outstanding production capacity, operational flexibility and cost-effectiveness. Featuring stable long-term operation, low maintenance consumption, and convenient formula switching, the system enables pharmaceutical manufacturers to achieve standardized, intelligent, and high-efficiency infusion production while lowering overall operational costs and enhancing core market competitiveness.
